Pharmaceutical companies in the United States by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Viatris has the lowest figure of the 34 pharmaceutical companies in the United States ranked by P/S ratio, at 1.6, followed by Amneal Pharmaceuticals (2.5) and Bristol-Myers Squibb (2.5). Figures as of 20 Nov 2026, 15:19 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 34
- Lowest
- Viatris1.6
- Median
- 7.9
- Combined market value
- THB 128.5T
- Countries
- 1
- Not ranked
- 10no P/S ratio on file
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | P/S ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ViatrisVTRS · Health Care | 1.6 | THB 775B | THB 675.97 | 0.33% up | 90% up | ||
| 2 | Amneal PharmaceuticalsAMRX · Health Care | 2.5 | THB 251.8B | THB 722.70 | 0.30% down | 79% up | ||
| 3 | Bristol-Myers SquibbBMY · Health Care | 2.5 | THB 4.13T | THB 2,019.84 | 2.16% up | 26% up | ||
| 4 | PfizerPFE · Health Care | 2.6 | THB 5.41T | THB 949.05 | 1.68% up | 10% up | ||
| 5 | Elanco Animal HealthELAN · Health Care | 2.8 | THB 446.2B | THB 892.66 | 0.19% up | 18% up | ||
| 6 | PTC TherapeuticsPTCT · Health Care | 2.8 | THB 165.3B | THB 1,978.67 | 0.10% up | 26% down | ||
| 7 | Legend BiotechLEGN · Health Care | 3.0 | THB 104.8B | THB 540.21 | 0.99% down | 43% down | ||
| 8 | ZoetisZTS · Health Care | 3.5 | THB 1.13T | THB 2,780.51 | 1.55% up | 34% down | ||
| 9 | BioMarin PharmaceuticalBMRN · Health Care | 3.7 | THB 402B | THB 2,075.42 | 0.29% down | 12% up | ||
| 10 | Abbott LaboratoriesABT · Health Care | 4.1 | THB 6.16T | THB 3,557.60 | 1.06% up | 19% down | ||
| 11 | Ionis PharmaceuticalsIONS · Health Care | 4.9 | THB 156.4B | THB 939.09 | 1.80% up | 64% down | ||
| 12 | Merck & CoMRK · Health Care | 5.2 | THB 11.43T | THB 4,638.02 | 3.05% up | 36% up | ||
| 13 | Alnylam PharmaceuticalsALNY · Health Care | 5.4 | THB 683.8B | THB 5,105.19 | 1.91% up | 66% down | ||
| 14 | Regeneron PharmaceuticalsREGN · Health Care | 6.8 | THB 3.29T | THB 31,807.63 | 1.75% up | 22% up | ||
| 15 | Johnson & JohnsonJNJ · Health Care | 6.9 | THB 22.18T | THB 9,214.69 | 1.78% up | 31% up | ||
| 16 | Arrowhead PharmaceuticalsARWR · Health Care | 7.4 | THB 207.6B | THB 1,468.45 | 0.73% down | 8% up | ||
| 17 | United TherapeuticsUTHR · Health Care | 7.5 | THB 806.8B | THB 18,944.51 | 0.02% down | 18% up | ||
| 18 | AbbVieABBV · Health Care | 8.4 | THB 17.33T | THB 9,804.04 | 2.03% up | 20% up | ||
| 19 | Corcept TherapeuticsCORT · Health Care | 9.3 | THB 240.8B | THB 2,200.65 | 0.07% down | 16% down | ||
| 20 | Travere TherapeuticsTVTX · Health Care | 9.5 | THB 158.4B | THB 1,650.48 | 0.83% up | 39% up | ||
| 21 | Madrigal PharmaceuticalsMDGL · Health Care | 9.5 | THB 309.7B | THB 13,334.02 | 0.83% down | 28% down | ||
| 22 | Axsome TherapeuticsAXSM · Health Care | 10.9 | THB 236.2B | THB 4,490.26 | 2.35% down | 9% down | ||
| 23 | Vertex PharmaceuticalsVRTX · Health Care | 11.1 | THB 4.53T | THB 17,861.72 | 1.23% up | 22% up | ||
| 24 | Mirum PharmaceuticalsMIRM · Health Care | 12.2 | THB 215.9B | THB 3,306.65 | 2.16% up | 35% up | ||
| 25 | TG TherapeuticsTGTX · Health Care | 15.9 | THB 332.7B | THB 2,201.32 | 0.12% up | 103% up | ||
| 26 | Royalty PharmaRPRX · Health Care | 16.5 | THB 1.33T | THB 2,318.58 | 1.03% up | 74% up | ||
| 27 | Eli LillyLLY · Health Care | 18.7 | THB 41.27T | THB 46,330.00 | 1.18% up | 28% up | ||
| 28 | Ligand PharmaceuticalsLGND · Health Care | 21.6 | THB 196.6B | THB 9,829.29 | 1.08% up | 44% up | ||
| 29 | BridgeBio PharmaBBIO · Health Care | 30.0 | THB 511.2B | THB 2,624.10 | 0.96% down | 15% up | ||
| 30 | Rhythm PharmaceuticalsRYTM · Health Care | 41.8 | THB 269B | THB 3,880.07 | 1.98% down | 15% up | ||
| 31 | InsmedINSM · Health Care | 52.2 | THB 1.07T | THB 4,887.28 | 0.17% down | 27% down | ||
| 32 | CytokineticsCYTK · Health Care | 83.6 | THB 249.6B | THB 1,791.43 | 2.72% up | 21% down | ||
| 33 | Protagonist TherapeuticsPTGX · Health Care | 173 | THB 270.2B | THB 4,140.34 | 1.49% down | 45% up | ||
| 34 | Dianthus TherapeuticsDNTH · Health Care | 2343 | THB 161.7B | THB 2,871.16 | 0.13% down | 105% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 33.8900 THB). 10 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which pharmaceutical companies in the United States have the lowest P/S ratio?
Viatris (1.6), Amneal Pharmaceuticals (2.5) and Bristol-Myers Squibb (2.5) have the lowest P/S ratio of the 34 pharmaceutical companies in the United States ranked here as of 20 Nov 2026, 15:19 UTC.
How many pharmaceutical companies in the United States are in this ranking?
34 are ranked by P/S ratio. 10 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these pharmaceutical companies in the United States worth together?
The 34 pharmaceutical companies in the United States ranked by P/S ratio have a combined market value of THB 128.5T as of 20 Nov 2026, 15:19 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies in the United States by P/S ratio”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.